DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Animal disease model
Animal disease model
Exosome TDP-43 Profile in Canine Model of ALS: a Preliminary Study in Developing Surrogate Biomarker
The Good and the Bad of CRISPR/Cas9 Genome Editing
Current and Emerging Treatment Options for Endometriosis
Lancl1 Promotes Motor Neuron Survival and Extends the Lifespan of Amyotrophic Lateral Sclerosis Mice
Preliminary Evidence for an Influence of Exposure to Polycyclic Aromatic
Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives
Stem Cell Trials Using Companion Animal Disease Models
Veklury: Assessment Report
Predictive Validity of Animal Pain Models? a Comparison of the Pharmacokineticepharmacodynamic Relationship for Pain Drugs in Rats and Humans
Animal Infection Models for Vaccine Development
Animal Models of Alzheimer's Disease and Drug Development
National Center for Advancing Translational Sciences 2014 Report
DEXEDRINE® (Dextroamphetamine Sulfate) SPANSULE® Sustained-Release Capsules and Tablets
Acrolein Scavenger Dimercaprol Offers Neuroprotection in an Animal Model
Pathophysiology of Obesity
Potential Role of Dexamphetamine in the Treatment of Non-Alcoholic Fatty Liver Disease: Hopes and Pitfalls
W O 2016/030369 A1 3 March 2016 (03.03.2016) W I PO I P CT
Central Nervous System Pathology in Preclinical MPS IIIB Dogs Reveals Progressive Changes in Clinically Relevant Brain Regions Martin T
Top View
THE SCIENTIFIC VALUE of NON-CLINICAL ANIMAL STUDIES in DRUG DEVELOPMENT ANIMAL STUDIES in DRUG DEVELOPMENT Peter Van Meer Van Peter
Somatic Size and Cav1.3 Channel Expression in Vulnerable and Resistant Motoneurons of the SOD1 Mouse Model of Amyotrophic Lateral Sclerosis
The Role of Glia in Canine Degenerative Myelopathy: Relevance to Human Amyotrophic Lateral Sclerosis
Coadministration of Lithium and Celecoxib Reverses Manic-Like Behavior and Decreases Oxidative Stress in a Dopaminergic Model of Mania Induced in Rats Samira S
In Vivo Studies for Drug Development Via Oral
Animal Models of Human Disease: Zebrafish Swim Into View
Vyndaqel, INN-Tafamidis
The Flaws and Human Harms of Animal Experimentation
What Is the Potential of Animal Models to Inform Occupational Therapy Theories and Interventions from the Perspective of Neuroscience?
MINIREVIEW Genomics and Clinical Medicine: Rationale for Creating
Norovirus Infection Causes Acute Self-Resolving Diarrhea in Wild-Type Neonatal Mice
Utility of Animal Gastrointestinal Motility and Transit Models in Functional Gastrointestinal Disorders
Iron Overload Resulting from the Chronic Oral Administration of Ferric Citrate Induces Parkinsonism Phenotypes in Middle-Aged Mice
[ F]MEFWAY Designed for Imaging Brain Serotonin
Stem Cell Transplantation in Neurological Diseases: Improving Effectiveness in Animal Models
Marijuana Compounds: a Nonconventional Approach to Parkinson’S Disease Therapy
A New Animal Model of the Schizophrenia Prodrome Alice Petty1,2, Xiaoying Cui1, Asad Ali1, Zilong Du1, Sunil Srivastav1, James P
Optogenetic Delivery of Trophic Signals in a Genetic Model of Parkinson's
Treatment of Depression Is Associated with Suppression of Nonspecific and Antigen-Specific TH1 Responses in Multiple Sclerosis
Consideration of Gut Microbiome in Murine Models of Diseases
The Flaws and Human Harms of Animal Experimentation
Non-Animal Models of Epithelial Barriers (Skin, Intestine and Lung)
FDA Commissioner's Fellowship Program Class of 2008
Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives
Borna Disease Virus Ingo Jordan and W